Goldman Sachs analyst Umang Choudhary downgrades Comstock Res (NYSE:CRK) from Neutral to Sell.
‘Quest Diagnostics Completes Leadership Succession As Jim Davis Becomes CEO And President, Joins Board Of Directors’
Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO and President, Joins Board of Directors (accesswire.com)
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic